Clinical trial
Comparison of Two Validated Endovascular Strategies for Refractory Vasospastic Stenosis After Non-traumatic Intracranial Haemorrhage Leading to Severe Brain Hypoperfusion: Chemical Versus Chemical and Mechanical Angioplasty
NCT05268445 is registered in ClinicalTrials.gov with Erasme University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Two Validated Endovascular Strategies for Refractory Vasospastic Stenosis After Non-traumatic Intracranial Haemorrhage Leading to Severe Brain Hypoperfusion: Chemical Versus Chemical and Mechanical Angioplasty
- Lead sponsor
- Erasme University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 1, 2022
- Completion date
- January 1, 2024
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aneurysmal subarachnoid hemorrhage, arteriovenous fistula, arteriovenous malformations, cerebral, ruptured cerebral aneurysm, stenosis, vasospasm, intracranial